The CDC's Advisory Committee on Immunization Practices has issued an updated set of influenza recommendations for the coming influenza season (MMWR "Recommendations and Reports," July 28). Principal changes from last year include:
Speaking of the possibility of a flu vaccine shortage: The Food and Drug Administration has approved four manufacturers' formulation of a flu vaccine for the 2006-2007 flu season. Those four (GlaxoSmithKline, Chiron, MedImmune, and Sanofi Pasteur) report that they expect to produce a total of 100 million doses for the coming season. But, as the FDA said in a statement, that projection could change as manufacturing continues.
FDA approves Pfizer’s maternal vaccine to prevent RSV in infants
August 21st 2023Approved for use at 32 weeks through 36 weeks gestation, Pfizer’s maternal respiratory syncytial vaccine (Abrysvo), is delivered through a single dose injection to the muscle, and is the first vaccine for use in pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD because of RSV in infants (birth to 6 months).
Combination test for COVID-19, influenza A/B, RSV receives FDA 510(k) clearance
August 3rd 2023Previously available under an Emergency Use Authorization, the combination test can detect and distinguish COVID-19, influenza A/B, and respiratory syncytial virus (RSV). The clearance comes ahead of respiratory season, which, according to BD, could result in another “tripledemic” threat.
2 Clarke Drive
Cranbury, NJ 08512